kabutan

Medical Data Vision Co.,Ltd.(3902) Summary

3902
TSE Prime
Medical Data Vision Co.,Ltd.
474
JPY
0
(0.00%)
Dec 5, 3:30 pm JST
3.06
USD
Dec 5, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
66.4
PBR
6.27
Yield
1.90%
Margin Trading Ratio
9.86
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
476 JPY 3.06 USD
Previous Close Dec 4
474 JPY 3.05 USD
High Dec 5, 9:27 am
483 JPY 3.11 USD
Low Dec 5, 9:02 am
470 JPY 3.02 USD
Volume
91,600
Trading Value
0.04B JPY 0.28M USD
VWAP
477.75 JPY 3.09 USD
Minimum Trading Value
47,400 JPY 306 USD
Market Cap
0.02T JPY 0.12B USD
Number of Trades
236
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
423
1-Year High Feb 12, 2025
1,575
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 223,700 1,012,000 4.52
Nov 21, 2025 214,300 1,019,000 4.76
Nov 14, 2025 219,600 1,069,800 4.87
Nov 7, 2025 227,600 1,110,400 4.88
Oct 31, 2025 214,900 1,130,800 5.26
Company Profile
Medical Data Vision Co., Ltd. provides a "Data Network" for hospital and medical information, as well as data utilization services of medical information for pharmaceutical companies.
Sector
Information & Communication
Medical Data Vision Co., Ltd. offers management support systems for hospitals and clinics while simultaneously collecting and storing medical and health information with consent from medical institutions and patients. By analyzing and utilizing this data, the company contributes to improving the quality of healthcare. Their main services include "MDV Act," a cloud-based hospital management improvement application; "EVE," a DPC (Diagnosis Procedure Combination) analysis benchmark system; and "Medical Code," a management issue resolution support system. Through the provision of these systems, the company has built a hospital network, which forms the basis for constructing a large-scale medical database. Utilizing this database, Medical Data Vision offers "MDV analyzer," a drug prescription analysis tool, and ad hoc survey services for pharmaceutical companies and research institutions. Additionally, the company has developed "Karteco," a PHR (Personal Health Record) service for patients.